Growth Metrics

Vertex Pharmaceuticals (VRTX) Intangibles (2016 - 2025)

Historic Intangibles for Vertex Pharmaceuticals (VRTX) over the last 17 years, with Q3 2025 value amounting to $429.8 million.

  • Vertex Pharmaceuticals' Intangibles fell 4831.65% to $429.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $429.8 million, marking a year-over-year decrease of 4831.65%. This contributed to the annual value of $825.9 million for FY2024, which is 166.69% down from last year.
  • According to the latest figures from Q3 2025, Vertex Pharmaceuticals' Intangibles is $429.8 million, which was down 4831.65% from $435.5 million recorded in Q2 2025.
  • In the past 5 years, Vertex Pharmaceuticals' Intangibles registered a high of $839.9 million during Q4 2023, and its lowest value of $387.0 million during Q2 2022.
  • In the last 5 years, Vertex Pharmaceuticals' Intangibles had a median value of $603.6 million in 2022 and averaged $572.7 million.
  • In the last 5 years, Vertex Pharmaceuticals' Intangibles soared by 5596.9% in 2023 and then plummeted by 4831.65% in 2025.
  • Over the past 5 years, Vertex Pharmaceuticals' Intangibles (Quarter) stood at $400.0 million in 2021, then surged by 50.9% to $603.6 million in 2022, then skyrocketed by 39.15% to $839.9 million in 2023, then decreased by 1.67% to $825.9 million in 2024, then crashed by 47.96% to $429.8 million in 2025.
  • Its Intangibles stands at $429.8 million for Q3 2025, versus $435.5 million for Q2 2025 and $441.2 million for Q1 2025.